Skip to main content
Premium Trial:

Request an Annual Quote

Protein Discovery Awarded Phase I SBIR Grant for Serum Fractionation

NEW YORK, March 8 (GenomeWeb News) - The National Institutes of Health has awarded Protein Discovery a Phase I SBIR Grant to help the company develop a fractionation system that prepares human serum for high-throuput mass-spectrometry analysis.


Protein Discovery's system "is compatible with all major MALDI mass spectrometers and can be automated, so we are excited about the tremendous value this system will provide to organizations involved in proteomics research and biomarker discovery," said president and CEO Chuck Witkowski in a statement.


The amount of the grant was not disclosed, though Phase I SBIR grants are typically $100,000.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.